Related references
Note: Only part of the references are listed.Rituximab in Lymphocyte-Predominant Hodgkin Disease
Hatem A. Azim et al.
ONCOLOGY (2009)
Lymphocyte-predominant and classical Hodgkin's lymphoma:: A comprehensive analysis from the German Hodgkin study group
Lucia Nogova et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL)-Clinicopathological Features Based on the Data of Two Hungarian Lymphoma Centres
A. Illes et al.
PATHOLOGY & ONCOLOGY RESEARCH (2008)
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
Holger Schulz et al.
BLOOD (2008)
Value of PET restaging after chemotherapy for non-Hodgkin's lymphoma: Implications for consolidation radiotherapy
Shannon T. Kahn et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
A Bräuninger et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage 1A lymphocyte-predominant Hodgkin's lymphoma:: a retrospective analysis from the German Hodgkin Study Group (GHSG)
L Nogová et al.
ANNALS OF ONCOLOGY (2005)
Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma
M García-Cosío et al.
MODERN PATHOLOGY (2004)
Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation
P Feugier et al.
BLOOD (2004)
Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma:: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma
L Boudová et al.
BLOOD (2003)
Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant hodgkin lymphoma. A report of 21 cases from the Nebraska Lymphoma Study Group
JZ Huang et al.
LEUKEMIA & LYMPHOMA (2003)
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial
BC Ekstrand et al.
BLOOD (2003)
Breast cancer in women after treatment for Hodgkin's disease
K Deniz et al.
LANCET ONCOLOGY (2003)
Gemcitabine, cisplatin and methylprednisolone chemotherapy (GEM-P) is an effective regimen in patients with poor prognostic primary progressive or multiply relapsed Hodgkin's and non-Hodgkin's lymphoma
I Chau et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: Report of an intergroup trial
DB Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Radiotherapy alone for lymphocyte-predominant Hodgkin's disease
PJ Schlembach et al.
CANCER JOURNAL (2002)
18-FDG-PET as a prognostic indicator in the treatment of aggressive non-Hodgkin's lymphoma-comparison with CT
NG Mikhaeel et al.
LEUKEMIA & LYMPHOMA (2000)
Share Paper
